MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 06.11.2025
SIGA Technologies Operativer Cashflow 2011-2025 | SIGA
Operativer Cashflow Jährlich SIGA Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94.8 M | 41.6 M | 11.5 M | 71.5 M | -18.2 M | 68.9 M | -18.4 M | -117 M | 11.1 M | 14.2 M | 58.4 M | -20.2 M | 25.6 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 94.8 M | -117 M | 17.2 M |
Operativer Cashflow Vierteljährlich SIGA Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 7.06 M | - | - | - | -6.12 M | - | - | - | 24.4 M | - | 49.7 M | - | 56.7 M | - | -4.61 M | - | -4.81 M | - | 25.6 M | -5.77 M | 3.32 M | - | -3.94 M | -4.34 M | 9.38 K | - | 72.5 M | -13.7 M | -8.56 M | - | -10.2 M | -2.61 M | -933 K | - | -90.9 M | -34.7 M | -8.64 M | - | 27.6 M | 13.9 M | -6.17 M | - | 18.6 M | 8.52 M | 16.6 M | - | 72.8 M | -6.89 M | -8.09 M | - | -25 M | -12.7 M | -6.49 M | - | -11.7 M | -8.76 M | -4.3 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 72.8 M | -90.9 M | 2.9 M |
Operativer Cashflow anderer Aktien in der Pharmaeinzelhändler
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-481 M | - | 2.43 % | $ 254 M |  Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
-85.9 M | $ 4.79 | -0.1 % | $ 795 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
-20.1 M | $ 3.02 | -0.66 % | $ 233 M |  USA |
 |
Aeglea BioTherapeutics
AGLE
|
-157 M | - | - | $ 1.01 B | USA |
 |
Alpine Immune Sciences
ALPN
|
-43.8 M | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-67.7 M | - | 4.14 % | $ 49.1 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-7.64 M | $ 0.21 | 22.69 % | $ 457 M |  Israel |
 |
Aptorum Group Limited
APM
|
-1.19 M | $ 1.16 | -0.85 % | $ 6.33 M |  China |
 |
Ampio Pharmaceuticals
AMPE
|
-8.56 M | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
-93.9 M | - | - | $ 10.1 M | USA |
 |
Midatech Pharma plc
MTP
|
-6.01 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Cellectar Biosciences
CLRB
|
-32.4 M | $ 2.51 | -9.05 % | $ 30.7 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-418 M | $ 209.26 | -1.67 % | $ 5 B |  Danmark |
 |
Aptevo Therapeutics
APVO
|
-23.8 M | $ 0.59 | -36.34 % | $ 163 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-12.3 M | $ 3.12 | 0.81 % | $ 7.51 B |  Australia |
 |
Biophytis SA
BPTS
|
-23.8 M | - | -13.47 % | $ 169 M |  France |
 |
BioVie
BIVI
|
-19 M | $ 1.22 | -4.33 % | $ 1.8 M | USA |
 |
Athersys
ATHX
|
-76.2 M | - | 3.77 % | $ 22.4 M | USA |
 |
Avenue Therapeutics
ATXI
|
-9.03 M | - | -52.27 % | $ 4.45 M | USA |
 |
ARCA biopharma
ABIO
|
-57.8 M | - | 1052.0 % | $ 415 M | USA |
 |
AVROBIO
AVRO
|
-63.2 M | - | 1083.1 % | $ 745 M | USA |
 |
Acasti Pharma
ACST
|
-14.9 M | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-141 M | - | -15.15 % | $ 60.3 M | Britain |
 |
BioDelivery Sciences International
BDSI
|
41 M | - | -4.8 % | $ 255 M | USA |
 |
Albireo Pharma
ALBO
|
-108 M | - | -0.23 % | $ 916 M | USA |
 |
BioNTech SE
BNTX
|
890 M | $ 94.66 | -0.39 % | $ 27.2 B | Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
213 M | $ 27.05 | 0.9 % | $ 1.31 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-141 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Anika Therapeutics
ANIK
|
-1.79 M | $ 9.6 | 1.21 % | $ 141 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-25.8 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
-47.5 M | - | -7.31 % | $ 87 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
66.5 M | $ 15.38 | - | $ 2 B | USA |
 |
bluebird bio
BLUE
|
-235 M | - | - | $ 546 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-452 M | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
-30.3 M | - | 2.71 % | $ 14 M | USA |
 |
Calithera Biosciences
CALA
|
-66.3 M | - | -10.95 % | $ 876 K | USA |
 |
Eton Pharmaceuticals
ETON
|
6.82 M | $ 16.89 | -0.59 % | $ 433 M | USA |
 |
Evogene Ltd.
EVGN
|
-24.7 M | $ 1.02 | -2.86 % | $ 27.9 M | Israel |
 |
Axon Enterprise
AXON
|
408 M | $ 585.1 | -1.02 % | $ 44.3 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-34.5 M | - | - | $ 7.46 M | Israel |
 |
Exelixis
EXEL
|
700 M | $ 46.12 | -0.84 % | $ 13.4 B | USA |
 |
Aytu BioScience
AYTU
|
-1.94 M | $ 2.48 | -2.17 % | $ 15.6 M | USA |
 |
AstraZeneca PLC
AZN
|
5.96 B | $ 92.69 | 0.26 % | $ 96.9 B | Britain |
|
Foghorn Therapeutics
FHTX
|
-100 M | $ 5.4 | - | $ 296 M | USA |
 |
Acorda Therapeutics
ACOR
|
-14 M | - | -24.86 % | $ 820 K | USA |
 |
Catalyst Biosciences
CBIO
|
25.9 M | $ 12.3 | -0.61 % | $ 810 M | USA |
 |
Brickell Biotech
BBI
|
-4.34 M | - | -5.38 % | $ 6.06 M | USA |